Beijing Hotgen Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	216.38	536.84	282.05	276.11	523.49	1,161
Short-Term Investments	-	-	601.14	50	50.95	-
Trading Asset Securities	983.95	830.33	201.51	280.02	888.68	927.45
Cash & Short-Term Investments	1,200	1,367	1,085	606.13	1,463	2,089
Cash Growth	9.04%	26.04%	78.95%	-58.57%	-29.94%	445.84%
Accounts Receivable	116.37	118.48	91.99	28.59	102.04	38.21
Other Receivables	5.49	1.36	4.15	28.93	17.01	47.36
Receivables	121.85	119.84	96.15	57.52	119.06	85.57
Inventory	88.41	79.36	85.56	137.21	154.25	258.62
Prepaid Expenses	-	-	-	0.15	2.6	-
Other Current Assets	45.09	30.62	41.71	38.9	59.24	84.98
Total Current Assets	1,456	1,597	1,308	839.91	1,798	2,518
Property, Plant & Equipment	875.95	902.19	1,081	1,193	867.94	562.12
Long-Term Investments	512.44	477.84	827.23	1,418	1,038	441.6
Other Intangible Assets	46.73	48.52	52.12	55.07	56.55	57.33
Long-Term Deferred Tax Assets	36.29	35.41	26.64	34.4	38.8	15.95
Long-Term Deferred Charges	17.54	20.15	25.77	24.3	23.2	22.32
Other Long-Term Assets	118.99	98.77	29.54	6.76	76.21	27.85
Total Assets	3,064	3,180	3,351	3,572	3,899	3,645

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	69.7	49.81	49.7	44.72	151.52	141.27
Accrued Expenses	37.32	38.66	32.67	25.55	177.68	167.53
Short-Term Debt	-	50.02	42.66	-	-	-
Current Portion of Leases	0.02	0.34	0.12	7.49	27.95	13
Current Income Taxes Payable	0.85	0.93	1.06	1.15	1.13	120.24
Current Unearned Revenue	17.82	13.14	16.7	28.08	56.98	267.05
Other Current Liabilities	53.36	95.15	141.91	81.05	96.06	25.08
Total Current Liabilities	179.07	248.03	284.81	188.04	511.31	734.16
Long-Term Leases	0.07	0.13	0.12	7.76	14.18	22.98
Long-Term Unearned Revenue	22.19	11.07	15.75	9.77	10.77	9.47
Long-Term Deferred Tax Liabilities	-	0.01	-	-	9.32	4.41
Other Long-Term Liabilities	271.69	264.05	-	-	-	-
Total Liabilities	473.02	523.29	300.69	205.57	545.59	771.01

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	92.75	92.71	92.47	92.27	92.05	62.2
Additional Paid-In Capital	240.84	163.82	334.61	444.04	435.31	458.31
Retained Earnings	2,419	2,545	2,761	2,994	2,958	2,323
Treasury Stock	-363.86	-338.55	-133.89	-166.48	-150.04	-
Comprehensive Income & Other	53.15	23.36	9.96	4.32	-0.03	-0.3
Total Common Equity	2,442	2,486	3,064	3,368	3,335	2,844
Minority Interest	148.9	170.32	-14.16	-2.12	18.46	30.31
Shareholders' Equity	2,591	2,657	3,050	3,366	3,354	2,874
Total Liabilities & Equity	3,064	3,180	3,351	3,572	3,899	3,645

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	0.1	50.49	42.9	15.26	42.13	35.98
Net Cash (Debt)	1,200	1,317	1,042	590.87	1,421	2,053
Net Cash Growth	14.24%	26.39%	76.31%	-58.42%	-30.77%	436.43%
Net Cash Per Share	12.91	14.38	11.95	6.69	15.46	22.30
Filing Date Shares Outstanding	88.17	87.93	89.58	89.41	89.53	92.05
Total Common Shares Outstanding	88.17	87.93	89.58	89.41	89.53	92.05
Working Capital	1,277	1,349	1,023	651.88	1,287	1,784
Book Value Per Share	27.69	28.28	34.20	37.67	37.25	30.89
Tangible Book Value	2,395	2,438	3,012	3,313	3,279	2,786
Tangible Book Value Per Share	27.16	27.72	33.62	37.06	36.62	30.27
Buildings	614.88	616.65	703.6	704.79	174.55	162.16
Machinery	544.09	543.25	581.09	575.66	399.88	317.94
Construction In Progress	0.86	0.12	5.62	48.18	374.44	121.71